The effect of trimetazidine on cardiac function in diabetic patients with idiopathic dilated cardiomyopathy

ATS Statement: Guidelines for the Six-Minute Walk Test

American Journal of Respiratory and Critical Care Medicine · 2002 · 10.8K citations

Medicine, Kinesiology, Physical Medicine +13

The Antianginal Drug Trimetazidine Shifts Cardiac Energy Metabolism From Fatty Acid Oxidation to Glucose Oxidation by Inhibiting Mitochondrial Long-Chain 3-Ketoacyl Coenzyme A Thiolase

Paul F. Kantor, Arnaud Lucien, Raymond Kozak et al. · Circulation Research · 2000 · 807 citations

Medicine, Cardiology, Pharmacology +17

Dilated cardiomyopathy

John L. Jefferies, Jeffrey A. Towbin · The Lancet · 2010 · 539 citations

A Randomized Clinical Trial of Trimetazidine, a Partial Free Fatty Acid Oxidation Inhibitor, in Patients With Heart Failure

Gabriele Fragasso, Altin Palloshi, Patrizia Puccetti et al. · Journal of the American College of Cardiology · 2006 · 268 citations

Medicine, Pharmacology, Pharmacotherapy +13

Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy

Helena Tuunanen, Erik Engblom, Kjell Någren et al. · Circulation · 2008 · 264 citations

Medicine, Cardiology, Pharmacology +15